三元生物：拟使用不超过22.00亿元闲置自有资金进行现金管理

Core Viewpoint - The company plans to utilize up to 2.2 billion yuan of temporarily idle self-owned funds for cash management, focusing on high-security and liquid financial products [1] Group 1: Board Meeting and Approval - The fifth board of directors' eleventh meeting will be held on February 4, 2026, to review the proposal for cash management [1] - The proposal aims to use idle funds for investments in cash management products issued by financial institutions such as commercial banks and securities companies [1] Group 2: Investment Details - The investment period for the cash management will be effective for 12 months from the date of approval by the first temporary shareholders' meeting in 2026 [1] - If any single transaction exceeds this period, the validity will automatically extend until the transaction matures [1] - The funds can be used on a rolling basis within the approved limit, ensuring no impact on the company's normal operations and investment project timelines [1]